| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.46 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |